《科学》 第393卷 第6812期 · 2026年8月13日 · 中文解读
“不匹配”埃博拉疫苗或即将广泛推广
‘Mismatched’ Ebola vaccine may soon be rolled out widely · Kai Kupferschmidt
约 11 分钟News在小程序里点播,20 到 60 分钟做好
这篇讲什么
新数据表明默克公司的埃博拉疫苗可能对罕见的本迪布焦病毒提供保护,世界卫生组织正在考虑在刚果民主共和国进行大规模试验。
原文开头
Opinions shift after new data suggest vaccine for Ebola Zaire may also protect against Bundibugyo KAI KUPFERSCHMIDT A s soon as the Democratic Republic of the Congo (DRC) declared its latest Ebola outbreak on 15 May, scientists and public health officials started arguing about the use of vaccines. The epidemic is caused by the Bundibugyo virus, a rare Ebola species for which no vaccines exist. But a debate erupted about trying the one licensed for a virus known as Zaire, the species that has caused the vast majority of past outbreaks. How much Ebola protection, if any, the Zaire vaccine—developed by Merck and called Ervebo—would offer against Bundibugyo remains unclear. …
摘自《科学》(Science)第393卷 第6812期 · 2026年8月13日,Kai Kupferschmidt。仅引用开头一小段供了解文章,版权归原刊所有,全文请阅读原刊。

微信扫码,在小程序里听完整版
不用登录先听一篇 · 或在微信搜索小程序 晨间信号